SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001393905-21-000284
Filing Date
2021-06-02
Accepted
2021-06-01 19:18:28
Documents
10
Period of Report
2021-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rtsl_8k.htm 8-K 60168
2 CERTIFICATE OF DESIGNATION SERIES B rtsl_ex31.htm EX-3.1 81843
3 CERTIFICATE OF DESIGNATION SERIES C rtsl_ex32.htm EX-3.2 82558
4 INDEPENDENT CONTRACTOR AGREEMENT WE THE 23 rtsl_ex101.htm EX-10.1 67900
5 TRADING AGREEMENT rtsl_ex102.htm EX-10.2 31893
6 INDEPENDENT CONTRACTOR AGREEMENT EPIC rtsl_ex103.htm EX-10.3 45450
7 PRESS RELEASE rtsl_ex104.htm EX-10.4 10095
8 IMAGE rtslex311.jpg GRAPHIC 185438
9 IMAGE rtslex321.jpg GRAPHIC 152342
10 IMAGE rtslex1041.jpg GRAPHIC 10242
  Complete submission text file 0001393905-21-000284.txt   861269
Mailing Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240
Business Address 5580 PETERSON LANE SUITE 200 DALLAS TX 75240 214-236-1363
Rapid Therapeutic Science Laboratories, Inc. (Filer) CIK: 0001575659 (see all company filings)

IRS No.: 462111820 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55018 | Film No.: 21987110
SIC: 2834 Pharmaceutical Preparations